Cargando…

Novel function of MDA-9/Syntenin (SDCBP) as a regulator of survival and stemness in glioma stem cells

Glioblastoma multiforme (GBM) is an aggressive cancer with current therapies only marginally impacting on patient survival. Glioma stem cells (GSCs), a subpopulation of highly tumorigenic cells, are considered major contributors to glioma progression and play seminal roles in therapy resistance, imm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Talukdar, Sarmistha, Das, Swadesh K., Pradhan, Anjan K., Emdad, Luni, Shen, Xue-Ning, Windle, Jolene J., Sarkar, Devanand, Fisher, Paul B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Priority Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342330/ https://www.ncbi.nlm.nih.gov/pubmed/27472461 http://dx.doi.org/10.18632/oncotarget.10851

Ejemplares similares

MDA-9/Syntenin (SDCBP) Is a Critical Regulator of Chemoresistance, Survival and Stemness in Prostate Cancer Stem Cells
por: Talukdar, Sarmistha, et al.
Publicado: (2019)

Knockout of MDA-9/Syntenin (SDCBP) expression in the microenvironment dampens tumor-supporting inflammation and inhibits melanoma metastasis
por: Das, Swadesh K., et al.
Publicado: (2016)

MDA-9/Syntenin (SDCBP) modulates small GTPases RhoA and Cdc42 via transforming growth factor β1 to enhance epithelial-mesenchymal transition in breast cancer
por: Menezes, Mitchell E., et al.
Publicado: (2016)

Regulation of neuroblastoma migration, invasion and in vivo metastasis by genetic and pharmacological manipulation of MDA-9/Syntenin
por: Bhoopathi, Praveen, et al.
Publicado: (2019)

Mechanism of internalization of MDA-7/IL-24 protein and its cognate receptors following ligand-receptor docking
por: Pradhan, Anjan K., et al.
Publicado: (2019)

MDA-7/IL-24 functions as a tumor suppressor gene in vivo in transgenic mouse models of breast cancer
por: Menezes, Mitchell E., et al.
Publicado: (2015)

Suppression of Her2/Neu mammary tumor development in mda-7/IL-24 transgenic mice
por: Li, You-Jun, et al.
Publicado: (2015)

Insights into the Mechanisms of Action of MDA-7/IL-24: A Ubiquitous Cancer-Suppressing Protein
por: Modi, Jinkal, et al.
Publicado: (2021)

Therapy of prostate cancer using a novel cancer terminator virus and a small molecule BH-3 mimetic
por: Sarkar, Siddik, et al.
Publicado: (2015)

AEG-1–AKT2: A novel complex controlling the aggressiveness of glioblastoma
por: Emdad, Luni, et al.
Publicado: (2015)

Transcriptional regulation of HSPB1 by Friend leukemia integration-1 factor modulates radiation and temozolomide resistance in glioblastoma
por: Rajesh, Yetirajam, et al.
Publicado: (2020)

Theranostic Tripartite Cancer Terminator Virus for Cancer Therapy and Imaging
por: Bhoopathi, Praveen, et al.
Publicado: (2021)

Cytoplasmic-delivery of polyinosine-polycytidylic acid inhibits pancreatic cancer progression increasing survival by activating Stat1-CCL2-mediated immunity
por: Bhoopathi, Praveen, et al.
Publicado: (2023)

Enhanced Cancer Therapy Using an Engineered Designer Cytokine Alone and in Combination With an Immune Checkpoint Inhibitor
por: Pradhan, Anjan K., et al.
Publicado: (2022)

Conversion of a Non-Cancer-Selective Promoter into a Cancer-Selective Promoter
por: Bhoopathi, Praveen, et al.
Publicado: (2022)

Src kinase activation is mandatory for MDA-9/syntenin-mediated activation of Nuclear Factor-κB
por: Boukerche, H., et al.
Publicado: (2010)

Identification of Genes Potentially Regulated by Human Polynucleotide Phosphorylase (hPNPase(old-35)) Using Melanoma as a Model
por: Sokhi, Upneet K., et al.
Publicado: (2013)

Targeted Apoptotic Effects of Thymoquinone and Tamoxifen on XIAP Mediated Akt Regulation in Breast Cancer
por: Rajput, Shashi, et al.
Publicado: (2013)

Mda-9/Syntenin Is Expressed in Uveal Melanoma and Correlates with Metastatic Progression
por: Gangemi, Rosaria, et al.
Publicado: (2012)

A PDZ Protein MDA-9/Syntenin: As a Target for Cancer Therapy
por: Yu, Yongsheng, et al.
Publicado: (2019)

MDA-9/Syntenin regulates differentiation and angiogenesis programs in head and neck squamous cell carcinoma
por: Oyesanya, Regina A., et al.
Publicado: (2014)

Embryonic stem cell (ESC)-mediated transgene delivery induces growth suppression, apoptosis, radiosensitization, and overcomes temozolomide resistance in malignant gliomas
por: Germano, Isabelle M., et al.
Publicado: (2010)

Therapy of pancreatic cancer via an EphA2 receptor-targeted delivery of gemcitabine
por: Quinn, Bridget A., et al.
Publicado: (2016)

The stem cell/cancer stem cell marker ALDH1A3 regulates the expression of the survival factor tissue transglutaminase, in mesenchymal glioma stem cells
por: Sullivan, Kelly E., et al.
Publicado: (2017)

SDCBP Modulates Stemness and Chemoresistance in Head and Neck Squamous Cell Carcinoma through Src Activation
por: Mir, Cristina, et al.
Publicado: (2021)

Combining histone deacetylase inhibitors with MDA-7/IL-24 enhances killing of renal carcinoma cells
por: Hamed, Hossein A, et al.
Publicado: (2013)

Syntenin is expressed in human gliomas and may correlate with tumor migration
por: Zhong, Dong, et al.
Publicado: (2015)

A framework for educating and empowering students by teaching about history and consequences of bias in STEM
por: Moreau, Corrie S, et al.
Publicado: (2022)

Oxidative Phosphorylation Fueled by Fatty Acid Oxidation Sensitizes Leukemic Stem Cells to Cold
por: Griessinger, Emmanuel, et al.
Publicado: (2023)

MDA-9/Syntenin-Slug transcriptional complex promote epithelial-mesenchymal transition and invasion/metastasis in lung adenocarcinoma
por: Wang, Lu-Kai, et al.
Publicado: (2015)

Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors
por: Liu, Qinghai, et al.
Publicado: (2009)

Effects of syndecan-1 on the expression of syntenin and the migration of U251 glioma cells
por: Chen, Jun, et al.
Publicado: (2017)

Sulforaphane reduces YAP/∆Np63α signaling to reduce cancer stem cell survival and tumor formation
por: Fisher, Matthew L., et al.
Publicado: (2017)

Role of the staphylococcal nuclease and tudor domain containing 1 in oncogenesis (Review)
por: JARIWALA, NIDHI, et al.
Publicado: (2014)

Staphylococcal nuclease domain containing-1 (SND1) promotes migration and invasion via angiotensin II type 1 receptor (AT1R) and TGFβ signaling
por: Santhekadur, Prasanna K., et al.
Publicado: (2014)

Stemness of the CT-2A Immunocompetent Mouse Brain Tumor Model: Characterization In Vitro
por: Binello, Emanuela, et al.
Publicado: (2012)

Comparison of SARS-CoV-2 RT-PCR on a high-throughput molecular diagnostic platform and the cobas SARS-CoV-2 test for the diagnostic of COVID-19 on various clinical samples
por: Opota, Onya, et al.
Publicado: (2020)

Mesenchymal stem cell infiltration during neoplastic transformation of the human prostate
por: Brennen, W. Nathaniel, et al.
Publicado: (2017)

Oncogenic KRAS activates an embryonic stem cell-like program in human colon cancer initiation
por: Le Rolle, Anne-France, et al.
Publicado: (2016)

Anti-tumoral effect of desmethylclomipramine in lung cancer stem cells
por: Bongiorno-Borbone, Lucilla, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8b50ot3dtl4a33q4iu96j5krqn